The Company is a digital and mobile healthcare platform in China. By applying advanced Internet and information technology.
The Company has two reportable segments: the B2C segment and the B2B segment. Product revenues from it B2C segment are generated from the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Company also generate product revenues from the B2B segment through the sale of pharmaceutical products to pharmacies on 1 Pharmacy.
History
2010 The Company was founded.
2013 The Company was incorporated under the laws of the Cayman Islands in May 2013.
2015 The Company was changed its name to New Peak Group in June 2015.
2018 The Company was changed its name to 111, Inc in April 2018 . On September 15, 2018, It ADSs commenced trading on Nasdaq under the symbol “YI.”
Headquarters
3Rd-4Th Floor, 295 Zuchongzhi Road, Pudong New Area
Shanghai; Shanghai;
Postal Code: 201203
Contact Details: Purchase the 111 Inc. report to view the information.
Website: http://www.111.com.cn
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service